logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore

prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Blue Jet Healthcare Ltd

Blue Jet Healthcare

Mid Cap447 EmployeesIPO 2023
Current Price
375.90
1.2 (0.32%)Updated
NSE :BLUEJET
BSE :544009
Today's Range
365.2
375.90
indicator
377.5
52 Week Range
52W Low352.55
52W High1027.80
375.90
indicator
Downside6.62%
Upside173.42%

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
6,277.71 Cr
Market Cap
Total market value of company
P/E Ratio
17.61
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
8.70
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
20.32
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
13.58%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
57.30%
ROCE
Return on Capital Employed. >15% is good
Net Margin
29.89%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
-%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
-%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
-%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.02
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
65.32
Book Value
Net asset value per share
Dividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
79.80%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • Exceptional ROE (52.10%) and ROCE (57.30%) demonstrate highly efficient capital utilization.
  • Robust Operating Profit Margin (41.30%) indicates strong operational efficiency and cost management.

Weaknesses

5 points
  • Elevated P/E ratio (80.20) significantly exceeds sector average (38.18), suggesting overvaluation.
  • Declining promoter and FII holdings signal reduced institutional confidence.

Opportunities

5 points
  • Positioned in robust Pharmaceuticals and Healthcare sector to capitalize on global expenditure.
  • Substantial room for market share expansion within the large pharmaceutical industry.

Threats

4 points
  • Intense competition from larger, established pharmaceutical players may limit market share.
  • High P/E ratio (80.20) creates valuation risk if future earnings growth disappoints.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

No insider trading data available

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4405.13+₹29.23+7.78%
R3392.83+₹16.93+4.50%
R2385.17+₹9.27+2.47%
R1380.53+₹4.63+1.23%
PIVOT372.87-3.03-0.81%
CURRENT375.90--
S1343.63-₹32.27-8.58%
S2355.93-₹19.97-5.31%
S3360.57-₹15.33-4.08%
S4368.23-₹7.67-2.04%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
4.49L
(11 Mar 2026)
-64.1% vs avg
Delivery %
55.0%
(11 Mar 2026)
+15.2% vs avg
Avg Volume (20D)
1.25M
(11 Feb - 11 Mar)
20-day average
Avg Delivery %
39.8%
(11 Feb - 11 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Sun Pharmaceutical Industries Ltd
4.12L ₹ Cr
Best Profit Growth
Shilpa Medicare Ltd
234.00 %
Highest Dividend Yield
Procter & Gamble Health Ltd
3.64 %

Peer Comparison

Company Name
AARTIPHARM
Aarti Pharmalabs Ltd
AETHER
Aether Industries Ltd
ALIVUS
Alivus Life Sciences Ltd
FDC
FDC Ltd
GRANULES
Granules India Ltd
MARKSANS
Marksans Pharma Ltd
NATCOPHARM
Natco Pharma Ltd
PGHL
Procter & Gamble Health Ltd
SANOFI
Sanofi India Ltd
SANOFICONR
Sanofi Consumer Healthcare India Ltd
SENORES
Senores Pharmaceuticals Ltd
SHILPAMED
Shilpa Medicare Ltd
SPARC
Sun Pharma Advanced Research Company Ltd
STAR
Strides Pharma Science Ltd
SUNPHARMA
Sun Pharmaceutical Industries Ltd
SUPRIYA
Supriya Lifescience Ltd
ZOTA
Zota Health Care Ltd

About

BLUEJET

Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited is a global pharmaceutical company specializing in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). These core products are crucial components used in the production of various pharmaceutical and healthcare products worldwide. Their diverse portfolio caters to a wide range of applications within the healthcare industry, solidifying their position as a significant player in the global pharmaceutical supply chain.

A key aspect of Blue Jet's business is its provision of contrast media intermediates. These are vital components in medical imaging procedures, contributing to improved diagnostics and patient care. Beyond contrast media, they also offer a range of niche pharmaceutical intermediates and APIs, demonstrating a commitment to serving specialized needs within the pharmaceutical sector. This strategic focus on specialized products allows them to cater to specific market demands and maintain a competitive edge.

The company further distinguishes itself by offering contract development and manufacturing organization (CDMO) and contract manufacturing organization (CMO) services. This encompasses a comprehensive range of services, including end-to-end solutions from the initial process development stage through to the commercialization of new chemical entities (NCEs), advanced intermediates, APIs, and building blocks. This integrated approach allows Blue Jet to provide a complete solution for clients, streamlining the drug development process from inception to market launch.

One of Blue Jet's established product lines is saccharin and its related salts. The development, manufacture, and marketing of this product showcases the company's expertise in both the production and commercialization of pharmaceutical chemicals. The continued success in this area highlights their ability to not only produce high-quality products, but also to effectively market and distribute them globally.

Blue Jet Healthcare Limited maintains a substantial international presence, with operations spanning multiple countries, including India, Norway, France, the United States, Italy, Sweden, and Spain. This global reach allows the company to effectively serve a diverse international clientele and participate in various key pharmaceutical markets. Their long history, dating back to their incorporation in 1968, and their headquarters in Thane, India, further establishes their experience and prominence within the industry.

COMPANY FACTS - BLUEJET

Registered Address

701, 702, 7th Floor, Plot No. 1 & 2, Bhumiraj Costarica, Sector 18, Sanpada

Mumbai

MAHARASHTRA

IN

Company Details

Group: Pharmaceuticals, Biotechnology & Life Sciences

Sector: Health Care

Industry: Pharmaceuticals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 447

IPO Date: 01/11/2023

MANAGEMENT - BLUEJET

Mr. Akshay Arora

Executive Chairman of the Board

Mr. Ganesh Karuppannan

Chief Financial Officer

Mr. Vimalendu Singh

Chief Operating Officer

Ms. Sweta Poddar

Compliance Officer, Company Secretary

Mr. Shiven Arora

Managing Director, Executive Director

Mr. Popat Kedar

Executive Whole-Time Director

Mr. Naresh Shah

Executive Director

Ms. Preeti Mehta

Non-Executive Independent Director

Ms. Divya Momaya

Non-Executive Independent Director

Mr. Girish Vanvari

Non-Executive Independent Director

Ms. Priyanka Yadav

Non-Executive Independent Director

Investor Questions Answered

Blue Jet Healthcare Ltd (BLUEJET) Stock FAQs

Get answers to the most common questions about Blue Jet Healthcare Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Blue Jet Healthcare Ltd (BLUEJET) is ₹375.9. Today, the stock has gained by ₹1.20 (0.32%), trading in a range of ₹365.2 to ₹377.5. The stock opened at ₹370.1 with a trading volume of 1,83,190 shares.
Blue Jet Healthcare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹6,277.71 crores, P/E ratio of 17.61, ROE of 13.58%, and ROCE of 57.30%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Blue Jet Healthcare Ltd (BLUEJET) is ₹1,027.8, while the 52-week low is ₹352.55. Currently trading at ₹375.9, the stock is 3.5% away from its 52-week low and 63.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Blue Jet Healthcare Ltd stock at ₹375.9 depends on multiple factors. The stock is currently trading with a P/E ratio of 17.61 and P/B ratio of N/A. Today's performance shows a gain of 0.32%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Blue Jet Healthcare Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹375.9, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Blue Jet Healthcare Ltd's key financial metrics include: P/E Ratio: 17.61, P/B Ratio: N/A, ROE: 13.58%, ROCE: 57.30%, Dividend Yield: 0.00%, EPS: ₹20.32, Book Value: ₹65.32, Debt-to-Equity: 0.02, and Current Ratio: N/A. The company's market cap stands at ₹6,277.71 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Blue Jet Healthcare Ltd stock opened at ₹370.1 and is currently trading at ₹375.9, showing a gain of ₹1.20 (0.32%). The intraday high is ₹377.5 and low is ₹365.2. The trading volume stands at 1,83,190 shares, indicating moderate market participation today.
Blue Jet Healthcare Ltd has a Price-to-Earnings (P/E) ratio of 17.61, which means investors are willing to pay ₹17.61 for every ₹1 of earnings. With an EPS of ₹20.32, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Blue Jet Healthcare Ltd has a market capitalization of ₹6,277.71 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹375.9) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Blue Jet Healthcare Ltd has a book value of ₹65.32 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹375.9, which is 475.5% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Blue Jet Healthcare Ltd has a Return on Equity (ROE) of 13.58% and Return on Capital Employed (ROCE) of 57.30%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These are moderate returns, suggesting decent operational efficiency. Higher percentages generally indicate better financial performance.
Blue Jet Healthcare Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Blue Jet Healthcare Ltd has a debt-to-equity ratio of 0.02, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Blue Jet Healthcare Ltd has an Earnings Per Share (EPS) of ₹20.32, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹375.9 and P/E ratio of 17.61, investors are paying 17.61 times the annual earnings per share. This moderate EPS suggests decent earnings generation. Track EPS growth over quarters to assess earnings momentum.
Blue Jet Healthcare Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Blue Jet Healthcare Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Blue Jet Healthcare Ltd stock, consider: 1) Fundamental Analysis - Review P/E (17.61), ROE (13.58%), debt-to-equity (0.02), and growth rates. 2) Technical Analysis - Check 52-week range (₹352.55 - ₹1027.80), moving averages, and chart patterns. 3) Valuation - Compare current price (₹375.90) with book value (₹65.32) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Blue Jet Healthcare Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹375.9 is 18695x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Blue Jet Healthcare Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹352.55 - ₹1027.80). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.02 indicates leverage. 4) Liquidity Risk - Based on trading volume of 1,83,190 shares. 5) Valuation Risk - P/E of 17.61 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Blue Jet Healthcare Ltd operates in the industry with key metrics: P/E ratio of 17.61, ROE of 13.58%, market cap of ₹6,277.71 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.02), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Blue Jet Healthcare Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹375.9, with a 52-week range of ₹352.55 to ₹1027.80. Based on fundamentals like P/E (17.61), ROE (13.58%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Blue Jet Healthcare Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹375.90. 2) Fundamental Deterioration - Declining ROE (currently 13.58%), increasing debt (D/E: 0.02), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Blue Jet Healthcare Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.